Investigating Modes of Progressive Mobility

NCT ID: NCT00787098

Last Updated: 2009-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

82 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-11-30

Study Completion Date

2009-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the effects of specific activities with and without an early therapeutic mobility (ETM) protocol among patients who experience three or more days of mechanical ventilation. A second purpose is to examine staff/delivery system and patient factors that influence the initiation and progression of activity with and without an ETM protocol. The hypothesis is that ETM protocols will result in improved patient outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The specific aims of this study are to:

1. Compare patient responses to selected modes of therapy (activity) without and with an ETM protocol

1. Molecular responses: markers of inflammation interleukin (IL)-6 and IL-10
2. Physiological responses: peripheral oxygen saturation, heart rate, blood pressure, new dysrhythmias
3. Safety/Unsafe events including pain, fatigue, line or tube dislodgement, fall or near fall
2. Determine the associations between duration and level of activity/ETM achieved and outcomes:

1. occurrence of delirium
2. occurrence of ventilator associated pneumonia
3. occurrence of deep vein thrombosis or pulmonary emboli
4. occurrence of acquired pressure ulcer
5. muscle strength
6. number of days mechanically ventilated
7. discharge location (after ICU)
3. Describe strategies used in the ICU to initiate and implement activity with and without an ETM protocol

1. use of personnel such as registered nurses, physical therapists, respiratory therapist and nursing assistants
2. use of equipment such as a walker, lift device, belt or bed
3. perception of sufficient time and abilities
4. Describe patient factors that are associated with implementation of ETM

1. Potentially modifiable exemplars: sedation, site of vascular access, physician orders
2. Potentially nonmodifiable exemplars: weight, consciousness, hemodynamic instability, terminal condition

This is a prospective, longitudinal, repeated measures study with a control period, run-in period and intervention period. Data will be collected during all three periods for comparison. During the control period, patients will receive standard care. Standard care in this institution does not include a program of progressive or early mobility but does include activities similar to the ETM protocol, implemented at the discretion of the staff. During the run-in period, subjects will receive a mix of standard care and the intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Care Mechanical Ventilation Intensive Care Muscular Atrophy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

RA begins data collection with chart review for demographic and explanatory variables, collects data for baseline muscle strength. During standard care period, PM will obtain information about the plan for activity for enrolled patients (turning, complete or partial weight-bearing i.e., reverse Trendelenberg positioning, ROM, sitting and walking) through discussion with the direct providers. RA will interview one provider about factors which influence the decision to implement activity or provide bedrest, including the presence of orders for bedrest or physical therapy. If activity is planned, the PM will observe and record the type and duration of activity, drawing serum biomarkers 20 minutes before and 20 minutes after the activity. If no activity is planned or activity duration is less than 10 minutes, serum for only baseline inflammatory biomarkers will be drawn. The RA will collect outcomes data within 24 hours of discharge from the ICU.

Group Type NO_INTERVENTION

No interventions assigned to this group

2

Identical procedures for date recruitment, consent and data collection will occur. In this phase, the Project Manager will promote the use of the ETM protocol through coaching (e.g., reminding staff of benefits of mobility, identification of available resources, or suggesting cessation of bedrest orders) and by participating in planning at least one 20-minute activity.

Group Type EXPERIMENTAL

ETM protocol

Intervention Type OTHER

ETM is 4 levels. Level 1, each receives repositioning from lateral to supine positions at even hours, totaling 60 minutes of activity/positioning over 24 hours. If tolerated, two periods of 20 minutes of supine position with a reverse trendelenberg position of 15-20 degrees will be used to promote orthostasis. Level 2 is turning every 2 hours, positioning in reverse trendelenberg at 15-25 degrees as tolerated, active resistance with ICU staff for 20 minutes daily for a total of 60-80 minutes of activity/positioning daily. At Level 3, 2 times 20 minutes of a sitting are added to active ROM and inbed turning (estimated 80-100 total minutes of activity daily). Sitting is in bed or with non-weightbearing assisted transfer to chair with backrest elevation at 75-90 degrees and legs in a dependent position. Level 3 interventions; minimal weight-bearing. Level 4, weight-bearing transfer to chair and ambulation are added to inbed turning.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ETM protocol

ETM is 4 levels. Level 1, each receives repositioning from lateral to supine positions at even hours, totaling 60 minutes of activity/positioning over 24 hours. If tolerated, two periods of 20 minutes of supine position with a reverse trendelenberg position of 15-20 degrees will be used to promote orthostasis. Level 2 is turning every 2 hours, positioning in reverse trendelenberg at 15-25 degrees as tolerated, active resistance with ICU staff for 20 minutes daily for a total of 60-80 minutes of activity/positioning daily. At Level 3, 2 times 20 minutes of a sitting are added to active ROM and inbed turning (estimated 80-100 total minutes of activity daily). Sitting is in bed or with non-weightbearing assisted transfer to chair with backrest elevation at 75-90 degrees and legs in a dependent position. Level 3 interventions; minimal weight-bearing. Level 4, weight-bearing transfer to chair and ambulation are added to inbed turning.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* P:F ratio \> 100
* FiO2 \< 60% and PEEP less than 10 cmH20
* hemodynamic stability ten minutes after turning (i.e., heart rate (HR) and/or systolic blood pressure (BP) changes less than 20% of baseline)
* baseline (rest) vitals signs of HR 50-110
* mean arterial pressure (MAP) 60-100 mmHg
* peripheral oxygenation saturation (SpO2) greater than 88%
* Sufficient cognition for progression to levels 2-4 of ETM to assist with out of bed positioning or movement
* a high degree of dependency on others for positioning is acceptable
* there are no exclusions based on gender or minority status.

Exclusion Criteria

* End-stage muscular dystrophy
* myasthenia gravis
* new quadriplegia
* coma
* increased intracranial pressure
* unrepaired hip fracture and multiple lower extremity fractures
* Patients experiencing active titration of intravenous vasoactive medications (e.g. dopamine, epinephrine, or norepinepherine) will be excluded
* concurrent use of a continuous lateral rotation bed
* patients for high risk of death will also be excluded
* MICU admission following a hospital stay of \>9 days in the past months
* age \>80 in the presence of 2 or more life-threatening illnesses
* diagnosis of an active stage IV malignancy
* status post cardiac arrest
* diagnosis of intracerebral hemorrhage requiring mechanical ventilation
* subjects over 400 pounds can be excluded from mobilization based on the judgment of the bedside nurse or project manager; if the risk for staff or patient harm from moving a patient with excessive weight is considered likely, mobilization will not occur.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hill-Rom

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Case Western Reserve University, Francis Payne Bolton School of Nursing

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chris Winkelman, PhD

Role: PRINCIPAL_INVESTIGATOR

Case Western Reserve University

References

Explore related publications, articles, or registry entries linked to this study.

Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Anderson L, Baker S, Sanchez M, Penley L, Howard A, Dixon L, Leach S, Small R, Hite RD, Haponik E. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med. 2008 Aug;36(8):2238-43. doi: 10.1097/CCM.0b013e318180b90e.

Reference Type BACKGROUND
PMID: 18596631 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CR-0076

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ventilatory Muscle Training in Stroke
NCT02828943 COMPLETED PHASE3
Strength Training and Stroke
NCT00629005 COMPLETED PHASE1/PHASE2
2025 Animal Assisted Therapy
NCT07227181 COMPLETED NA
Early Mobilization in Intensive Therapy
NCT01549808 UNKNOWN PHASE1/PHASE2